menu
    • menu

    Company profile for Tyra Biosciences

    NEW Drugs in Dev: 5
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tyra Biosciences is targeting new pathways of acquired resistance in oncology with purpose-built drugs for the benefit of patients. Acquired resistance is a devastating reality for patients initially responding to targeted cancer therapies. As new therapies have become more selective, resistance has become a major limitation. The need from patients and the demand from the market to address this problem has never been stronger....
    Tyra Biosciences is targeting new pathways of acquired resistance in oncology with purpose-built drugs for the benefit of patients. Acquired resistance is a devastating reality for patients initially responding to targeted cancer therapies. As new therapies have become more selective, resistance has become a major limitation. The need from patients and the demand from the market to address this problem has never been stronger. Tyra has built a nimble and experienced team to rapidly translate new discoveries into the clinic with a singular focus on acquired resistance in oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tyra BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2333 State St. Suite 201, Carlsbad, CA 92008
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tyra.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tyra-biosciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tyra Biosciences To Participate In Upcoming Investor Conferences
    Tyra Biosciences To Participate In Upcoming Investor Conferences

    19 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tyra-biosciences-to-participate-in-upcoming-investor-conferences-302692883.html

    PR NEWSWIRE
    19 Feb 2026
    Share Share
    Tyra Biosciences To Participate In Investor Conferences
    Tyra Biosciences To Participate In Investor Conferences

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tyra-biosciences-announces-participation-at-upcoming-investor-events-302613236.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Tyra Biosciences Reveals Q3 2025 Financial Results
    Tyra Biosciences Reveals Q3 2025 Financial Results

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tyra-biosciences-reports-third-quarter-2025-financial-results-and-highlights-302606089.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Tyra Biosciences Doses 1st Child in Ph2 Pediatric Achondroplasia
    Tyra Biosciences Doses 1st Child in Ph2 Pediatric Achondroplasia

    21 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tyra-biosciences-announces-first-child-dosed-in-beach301-its-phase-2-study-for-dabogratinib-tyra-300-in-pediatric-achondroplasia-302535255.html

    PR NEWSWIRE
    21 Aug 2025
    Share Share
    Tyra Biosciences to Participate in Upcoming Investor Events
    Tyra Biosciences to Participate in Upcoming Investor Events

    20 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tyra-biosciences-announces-participation-at-upcoming-investor-events-302534890.html

    PR NEWSWIRE
    20 Aug 2025
    Share Share
    Tyra Biosciences Reports Q2 2025 Financial Results
    Tyra Biosciences Reports Q2 2025 Financial Results

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tyra-biosciences-reports-second-quarter-2025-financial-results-and-highlights-302530524.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search